JACINTO RICHARD II

JACINTO RICHARD II, 10% Owner, has filed 1 SEC report (2025), all concentrated in DiaMedica Therapeutics Inc. (DMAC), totaling $1.4M in disclosed volume. Weighing $1.4M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1.4M in DiaMedica Therapeutics Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.